SSC

Spruce Street Capital Portfolio holdings

AUM $416M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$416M
AUM Growth
+$113M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$20.4M
2
+$14.4M
3
+$11.1M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$10.5M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.3M

Top Sells

1
+$51.3M
2
+$41M
3
+$17.9M
4
OCUL icon
Ocular Therapeutix
OCUL
+$9.52M
5
PCVX icon
Vaxcyte
PCVX
+$8.4M

Sector Composition

1 Healthcare 98.78%
2 Financials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALEC icon
26
Alector
ALEC
$243M
$4.52M 1.09%
2,101,068
+983,082
LONA
27
LeonaBio Inc
LONA
$91.2M
$3.84M 0.92%
393,701
CRVS icon
28
Corvus Pharmaceuticals
CRVS
$1.08B
$3.39M 0.81%
+231,585
ABVX
29
Abivax
ABVX
$9.96B
– –
-49,119
CDTX
30
DELISTED
Cidara Therapeutics
CDTX
– –
-232,269
HELP
31
Cybin Inc
HELP
$220M
– –
-770,000
EYPT icon
32
EyePoint Inc
EYPT
$1.08B
– –
-981,543
OCUL icon
33
Ocular Therapeutix
OCUL
$1.79B
– –
-783,999
STRO icon
34
Sutro Biopharma
STRO
$440M
– –
-75,594
1
2